Regulation of the angiogenesis of acquired middle ear cholesteatomas by inhibitor of DNA binding transcription factor

JAMA Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 3, 2013, Pages 273-278

  Fukudome, Shinji ^a   Wang, Chuan ^a   Hamajima, Yuki ^a   Ye, Shengnan ^a,b   Zheng, Yiqing ^a,c   Narita, Norihiko ^d   Sunaga, Hiroshi ^d   Fujieda, Shigeharu ^d   Hu, Xiaohua ^a   Feng, Ling ^a   Lin, Jizhen ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CYCLOOXYGENASE 2; INHIBITOR OF DIFFERENTIATION 1; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR A; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84875827286     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2013.1750     Document Type: Article

References (32)

1. Bujía J, Holly A, Stammberger M, Sudhoff H. Angiogenesis in cholesteatoma of the middle ear. Acta Otorrinolaringol Esp. 1996;47(3):187-192.
2. Olszewska E, Chodynicki S, Chyczewski L. Role of angiogenesis in the pathogenesis of cholesteatoma in adults. Otolaryngol Pol. 2004;58(3):559-563.
3. Hasina R, Whipple ME, Martin LE, Kuo WP, Ohno-Machado L, Lingen MW. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Lab Invest. 2008;88(4):342-353. (Pubitemid 351432778)
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18(1):4-25. (Pubitemid 27076453)
5. Hasina R, Lingen MW. Angiogenesis in oral cancer. J Dent Educ. 2001;65(11):1282-1290.
6. Chen Z, Colon I, Ortiz N, et al. Effects of interleukin-1α, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res. 1998;58(16):3668-3676 (Pubitemid 28376567)
7. Sudhoff H, Dazert S, Gonzales AM, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol. 2000;21(6):793-798
8. Jin BJ, Min HJ, Jeong JH, Park CW, Lee SH. Expression of EGFR and microvessel density in middle ear cholesteatoma. Clin Exp Otorhinolaryngol. 2011;4 (2):67-71.
9. Lee YW, Chung Y, Juhn SK, Kim Y, Lin J. Activation of the transforming growth factor beta pathway in bacterial otitis media. Ann Otol Rhinol Laryngol. 2011 120(3):204-213.
10. Juhn SK, Jung MK, Hoffman MD, et al. The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol. 2008; 1(3):117-138.
11. Kakiuchi M, Tsujigiwa H, Orita Y, et al. Cyclooxygenase 2 expression in otitis media with effusion. Am J Otolaryngol. 2006;27(2):81-85 (Pubitemid 43267271)
12. Zhang QA, Hamajima Y, Zhang Q, Lin J. Identification of Id1 in acquired middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg. 2008;134(3):306-310 (Pubitemid 351439260)
13. Hamajima Y, Komori M, Preciado DA, et al. The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media. Cell Prolif. 2010;43:457-463
14. Valdimarsdottir G, Goumans MJ, Rosendahl A, et al. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation. 2002 106(17):2263-2270 (Pubitemid 35222223)
15. Lyden D, Young AZ, Zagzag D, et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 1999;401(6754) 670-677
16. Volpert OV, Pili R, Sikder HA, et al. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell. 2002;2(6):473-483 (Pubitemid 41043952)
17. Bancroft CC, Chen Z, Dong G, et al. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-κB signal pathways. Clin Cancer Res. 2001 7(2):435-442. (Pubitemid 32183050)
18. Klenke FM, Gebhard MM, Ewerbeck V, Abdollahi A, Huber PE, Sckell A. The selective Cox-2 inhibitor celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. BMC Cancer. 2006; 6:9. doi:10.1186/1471-2407-6-9. (Pubitemid 43193494)
19. Rhim JS, Jay G, Arnstein P, Price FM, Sanford KK, Aaronson SA. Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science. 1985;227(4691):1250-1252 (Pubitemid 15142017)
20. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745-2756
21. Ozeki M, Hamajima Y, Feng L, Ondrey FG, Schlentz E, Lin J. Id1 induces the proiferation of cochlear sensorineural epithelial cells via the nuclear factor-κB/cyclin D1 pathway in vitro. J Neurosci Res. 2007;85(3):515-524
22. Franzoso G, Bours V, Azarenko V, et al. The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select KB sites. EMBOJ. 1993;12(10):3893-3901 (Pubitemid 23282765)
23. Israel DI, Kaufman RJ. Highly inducible expression from vectors containing multiple GRE's in CHO cells overexpressing the glucocorticoid receptor. Nucleic Acids Res. 1989;17(12):4589-4604. (Pubitemid 19165032)
24. Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells: involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem. 1995; 270(42):24965-24971
25. Lin J, Tsuprun V, Kawano H, et al. Characterization of mucins in human middle ear and eustachian tube. Am J Physiol Lung Cell Mol Physiol. 2001;280(6) L1157-L1167.
26. Tokuriki M, Noda I, Saito T, et al. Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays. Laryngoscope. 2003;113 (5):808-814. (Pubitemid 36539152)
27. Cherukuri DP, Goulet AC, Inoue H, Nelson MA. Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-κB) in colon cancer cells. Cancer Biol Ther 2005;4(2):175-180 (Pubitemid 41351315)
28. Qiu J, Peng Q, Zheng Y, et al. OxLDL stimulates Id1 nucleocytoplasmic shuttling in endothelial cell angiogenesis via PI3K pathway. Biochim Biophys Acta. 2012; 1821(10)1361-1369.
29. Li W, Wang H, Kuang CY, et al. An essential role for the Id1/PI3K/Akt/NFκB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem. 2012;363(1-2):135-145
30. Jiang BH, Zheng JZ, Aoki M, Vogt PK. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A. 2000;97(4):1749-1753 (Pubitemid 30118514)
31. Zachary I. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem Soc Trans. 2003;31(pt 6):1171-1177 (Pubitemid 38030933)
32. Lin J, Guan Z, Wang C, et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-κB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res. 2010;16: 77-87.